Marko Salmi
12Patents
4h-index
5Co-inventors
53Inventor score
Filing activity: Sep 15, 1994 → Mar 25, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5616468A | Compositions and diagnostic methods using monoclonal antibodies against CD44v6 | Emerging Cross-Sectional Technologies | 15 | Expired |
| US7910097B2 | Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof | Human Necessities | 4 | Active |
| US9238550B2 | Conveyor beam | Mechanical Engineering; Lighting; Heating | 4 | Active |
| US5580780A | Vascular adhesion protein-(VAP-1) and VAP-1-specific antibodies | Chemistry; Metallurgy | 4 | Expired |
| US6066321A | Method for antagonizing vascular adhesion protein-1 (VAP-1)-mediated binding of endothelial cells to lymphocytes | Chemistry; Metallurgy | 3 | Expired |
| US5512442A | Detection of vascular adhesion protein-1 (VAP-1) | Chemistry; Metallurgy | 2 | Expired |
| US7354577B2 | Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof | Human Necessities | 2 | Expired |
| US8975081B2 | Biomarker for monitoring development of diseases and assessing the efficacy of therapies | Physics | 1 | Active |
| US8119651B2 | Compositions useful especially for treatment or prevention of metabolic syndrome | Human Necessities | 0 | Active |
| US10247730B2 | Method for determining acute respiratory distress syndrome (ARDS) related biomarkers, a method to monitor the development and treatment of ARDS in a patient | Physics | 0 | Active |
| US10526607B2 | Cell and therapeutical and diagnostical methods based thereon | Human Necessities | 0 | Active |
| US8722045B2 | Cell and therapeutical and diagnostical methods based thereon | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.